ImClone says data show Erbitux with radiation prevents spread of head, neck cancer

NEW YORK (AP) - Shares of biotechnology firm ImClone Systems Inc. soared Wednesday after the company said a late-stage study showed that its Erbitux drug is effective in preventing the spread of head and neck cancer....More